⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast Cancer

Official Title: Double-blind, Randomized, Multicenter, Phase III Clinical Study to Compare the Efficacy and to Evaluate the Safety and Immunogenicity of Trastuzumab Biosimilar HLX02 and EU-sourced Herceptin® in Previously Untreated HER2 Overexpressing Metastatic Breast Cancer

Study ID: NCT03084237

Conditions

Breast Cancer

Study Description

Brief Summary: This is a Phase III, double-blind, randomized multicenter study to compare the efficacy and to evaluate the safety and immunogenicity of HLX02 and European Union (EU)-sourced Herceptin® in patients with human epidermal growth factor receptor 2 (HER2)-positive, locally recurrent or previously untreated metastatic breast cancer.

Detailed Description: This is a Phase III, double-blind, randomized multicenter study to compare the efficacy and to evaluate the safety and immunogenicity of HLX02 and European Union (EU)-sourced Herceptin® in patients with human epidermal growth factor receptor 2 (HER2)-positive, recurrent or previously untreated metastatic breast cancer. Eligible patients will be assessed centrally for HER2 status and the presence of at least one measurable target lesion before randomization. Patients will undergo a tumor assessment for evaluation of response according to Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) every 6 weeks up to 24 weeks (regardless of the number of cycles actually given); thereafter, assessments will be done every 9 weeks (after Cycles 11, 14, and 17) or earlier in the case of clinical signs of progression.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

The Second Hospital of Anhui Medical University, Hefei, Anhui, China

Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China

Chongqing University Cancer Hospital, Chongqing, Chongqing, China

Fujian Cancer Hospital, Fuzhou, Fujian, China

Fujian Medical University Union Hospital, Fuzhou, Fujian, China

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong, China

First Affiliated Hospital of Guangzhou University of TMC, Guangzhou, Guangdong, China

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China

Sun Yat-sen University, Cancer Center, Guanzhou, Guangdong, China

The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China

Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China

Liuzhou General Hospital, Liuzhou, Guangxi, China

Affiliated Hospital of Hebei University, Baoding, Hebei, China

Hebei Cangzhou Central Hospital, Cangzhou, Hebei, China

The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

Henan Cancer Hospital, Zhengzhou, Henan, China

Hubei Cancer Hospital, Wuhan, Hubei, China

Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, China

The 2nd Xiangya Hospital of Central South University, Changsha, Hunan, China

The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Jiangsu Cancer Hospital, Nanjing, Jiangsu, China

Jiangsu Province Hospital, Nanjing, Jiangsu, China

Nanjing Bayi Hospital, Nanjing, Jiangsu, China

The Affiliated Drum Tower Hospital of Nanjing University, Nanjing, Jiangsu, China

Nantong Tumor Hospital, Nantong, Jiangsu, China

Wuxi 4th People's Hospital, Wuxi, Jiangsu, China

Xuzhou Central Hospital, Xuzhou, Jiangsu, China

Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China

The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

The First Hospital of Jilin University, Chang chun, Jilin, China

Jilin Cancer Hospital, Changchun, Jilin, China

Jilin Province People's Hospital, Changchun, Jilin, China

The Second Hospital of Dalian Medical University, Dalian, Liaoning, China

General Hospital of the Northern Theater of the Chinese People's Liberation Army, Shenyang, Liaoning, China

Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China

The First Hospital of China Medical University, Shenyang, Liaoning, China

Affiliated Hospital of Qinghai University, Xining, Qinghai, China

Affiliated Hospital of Jining Medical University, Jining, Shandong, China

Jinan Central Hospital, Jinan, Shangdong, China

Yantai Yuhuangding Hospital, Yantai, Shangdong, China

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Ruijin Hospital of Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China

Shannxi Provincial Tumor Hospital, Xi'an, Shangxi, China

The 2nd Hospital of Xi'An Jiaotong University, Xi'an, Shanxi, China

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China

West China Hospital, Sichuan University, Chengdu, Sichuan, China

Nanchong Central Hospital, Nanchong, Sichuan, China

Tianjin Medical University Cancer Institute & Hospital, Tianjing, Tianjing, China

Yunnan Cancer Hospital, Kunming, Yunnan, China

Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China

The First Affiliated Hospital, College of Medicine, Zhejiang University, HanGzhou, Zhejiang, China

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Beijing Cancer Hospital, Beijing, , China

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, , China

Chinese PLA General Hospital, Beijing, , China

Peking Union Medical College Hospital, Beijing, , China

Metro Davao Medical and Research Center, Inc., Davao City, Davao, Philippines

Cardinal Santos Medical Center, San Juan, La Union, Philippines

Manila Doctors Hospital, Manila, Metro Manila, Philippines

The Medical City, Pasig City, Metro Manila, Philippines

Cebu Doctors University Hospital, Cebu City, , Philippines

CI Kryvyi Rih Oncological Dispensary of DRC, Kryvyi Rih, Dnepropetrovsk, Ukraine

CNE"City Clin Hosp#4"of Dnipro City Council Dept of Chemotherapy SI Dnipropetrovsk MA of MOHU, Dnipro, Dnipropetrovsk, Ukraine

CI Carpathian Clinical Oncological Center, Ivano-Frankivs'k, Ivano-Frankivsk, Ukraine

CNE CCCH of Uzh CC Oncological Center, Ther Dept, SHEI UNU, Uzhgorod, Outer Carpathian, Ukraine

Transcarpathian Regional Clinical Oncological Dispensary, Uzhgorod, Outer Carpathian, Ukraine

Communal Enterprise Volyn Regional Medical Center of Oncology of Volyn Regional Council, Lutsk, Warren, Ukraine

CTPI Chernihiv Regional Oncological Dispensary, Chernihiv, , Ukraine

CI Chernivtsi RC Oncological Dispensary, Chernivtsi, , Ukraine

Communal Non-profit Enterprise Regional Center of Oncology, Kharkiv, , Ukraine

CI of Kherson Reg Council Kherson Regional Oncologic Dispensary, Kherson, , Ukraine

Khmelnytskyi Regional Oncological Dispensary, Khmelnytskyi, , Ukraine

Treatment-Diagnostic Center of Private Enterprise of PPC Atsynus, Kropyvnytskyi, , Ukraine

National Institute of Cancer, Kyiv, , Ukraine

CNE Kyiv City Clin Oncological Center of Ex Body of Kyiv CC(KCSA), Kyiv, , Ukraine

Kyiv Сity Clinical Oncological Center, Kyiv, , Ukraine

CI of LRC Lviv Oncological Regional Treatment and Diagnostic Center, Lviv, , Ukraine

CI Odesa Regional Clinical Hospital, Odesa, , Ukraine

Odesa Regional Oncologic Dispensary, Odesa, , Ukraine

Poltava Reg Cl Onc Dispensary of PRC Chemotherapy Dept HSEI of Ukr UMSA, Poltava, , Ukraine

RCI Sumy Regional Clinical Oncological Dispensary Dept of of Chemotherapy Sumy SU, Sumy, , Ukraine

Podilskyi Regional Oncological Center, Vinnytsia, , Ukraine

CI Zaporizhzhia RC Onc Dispensary of ZRC Dept of Breast Pathology SI Zaporizhzhia MA of PGE of MoHU, Zaporizhzhia, , Ukraine

CI Zaporizhzhia Regional Clinical Oncological Dispensary of ZRC, Zaporizhzhia, , Ukraine

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: